Evaluation	B:C0220825
of	O
Outpatient	O
Antibiotic	O
Use	O
in	O
Beijing	O
General	O
Hospitals	I:C0020008
in	O
2015	O
Medical	O
misuse	O
of	O
antibiotic	O
s	O
is	O
associated	O
with	O
the	O
acquisition	O
and	O
spread	O
of	O
antibiotic	O
resistance	I:C1326848
,	O
resulting	O
in	O
a	O
lack	O
of	O
effective	O
drugs	O
and	O
increased	O
health	O
-	O
care	O
cost	O
.	O

Evaluation	O
of	O
Outpatient	O
Antibiotic	B:C0003232
Use	O
in	O
Beijing	O
General	O
Hospitals	I:C0020008
in	O
2015	O
Medical	O
misuse	O
of	O
antibiotic	O
s	O
is	O
associated	O
with	O
the	O
acquisition	O
and	O
spread	O
of	O
antibiotic	O
resistance	I:C1326848
,	O
resulting	O
in	O
a	O
lack	O
of	O
effective	O
drugs	O
and	O
increased	O
health	O
-	O
care	O
cost	O
.	O

Evaluation	O
of	O
Outpatient	O
Antibiotic	O
Use	O
in	O
Beijing	B:C4042832
General	O
Hospitals	I:C0020008
in	O
2015	O
Medical	O
misuse	O
of	O
antibiotic	O
s	O
is	O
associated	O
with	O
the	O
acquisition	O
and	O
spread	O
of	O
antibiotic	O
resistance	I:C1326848
,	O
resulting	O
in	O
a	O
lack	O
of	O
effective	O
drugs	O
and	O
increased	O
health	O
-	O
care	O
cost	O
.	O

Evaluation	O
of	O
Outpatient	O
Antibiotic	O
Use	O
in	O
Beijing	O
General	B:C0020008
Hospitals	I:C0020008
in	O
2015	O
Medical	O
misuse	O
of	O
antibiotic	O
s	O
is	O
associated	O
with	O
the	O
acquisition	O
and	O
spread	O
of	O
antibiotic	O
resistance	I:C1326848
,	O
resulting	O
in	O
a	O
lack	O
of	O
effective	O
drugs	O
and	O
increased	O
health	O
-	O
care	O
cost	O
.	O

Evaluation	O
of	O
Outpatient	O
Antibiotic	O
Use	O
in	O
Beijing	O
General	O
Hospitals	I:C0020008
in	O
2015	O
Medical	B:C0199168
misuse	O
of	O
antibiotic	O
s	O
is	O
associated	O
with	O
the	O
acquisition	O
and	O
spread	O
of	O
antibiotic	O
resistance	I:C1326848
,	O
resulting	O
in	O
a	O
lack	O
of	O
effective	O
drugs	O
and	O
increased	O
health	O
-	O
care	O
cost	O
.	O

Evaluation	O
of	O
Outpatient	O
Antibiotic	O
Use	O
in	O
Beijing	O
General	O
Hospitals	I:C0020008
in	O
2015	O
Medical	O
misuse	B:C0549649
of	O
antibiotic	O
s	O
is	O
associated	O
with	O
the	O
acquisition	O
and	O
spread	O
of	O
antibiotic	O
resistance	I:C1326848
,	O
resulting	O
in	O
a	O
lack	O
of	O
effective	O
drugs	O
and	O
increased	O
health	O
-	O
care	O
cost	O
.	O

Evaluation	O
of	O
Outpatient	O
Antibiotic	O
Use	O
in	O
Beijing	O
General	O
Hospitals	I:C0020008
in	O
2015	O
Medical	O
misuse	O
of	O
antibiotic	B:C0003232
s	O
is	O
associated	O
with	O
the	O
acquisition	O
and	O
spread	O
of	O
antibiotic	O
resistance	I:C1326848
,	O
resulting	O
in	O
a	O
lack	O
of	O
effective	O
drugs	O
and	O
increased	O
health	O
-	O
care	O
cost	O
.	O

Evaluation	O
of	O
Outpatient	O
Antibiotic	O
Use	O
in	O
Beijing	O
General	O
Hospitals	I:C0020008
in	O
2015	O
Medical	O
misuse	O
of	O
antibiotic	O
s	O
is	O
associated	O
with	O
the	O
acquisition	O
and	O
spread	O
of	O
antibiotic	B:C1326848
resistance	I:C1326848
,	O
resulting	O
in	O
a	O
lack	O
of	O
effective	O
drugs	O
and	O
increased	O
health	O
-	O
care	O
cost	O
.	O

Evaluation	O
of	O
Outpatient	O
Antibiotic	O
Use	O
in	O
Beijing	O
General	O
Hospitals	I:C0020008
in	O
2015	O
Medical	O
misuse	O
of	O
antibiotic	O
s	O
is	O
associated	O
with	O
the	O
acquisition	O
and	O
spread	O
of	O
antibiotic	O
resistance	I:C1326848
,	O
resulting	O
in	O
a	O
lack	O
of	O
effective	O
drugs	B:C0013227
and	O
increased	O
health	O
-	O
care	O
cost	O
.	O

Nevertheless	O
,	O
inappropriate	O
antibiotic	B:C0003232
use	O
in	O
China	O
remains	O
common	O
and	O
the	O
situation	O
requires	O
urgent	O
improvement	O
.	O

Nevertheless	O
,	O
inappropriate	O
antibiotic	O
use	O
in	O
China	B:C0008115
remains	O
common	O
and	O
the	O
situation	O
requires	O
urgent	O
improvement	O
.	O

Here	O
,	O
we	O
analyzed	B:C0936012
the	O
prescriptions	O
of	O
antibiotics	O
and	O
evaluated	O
the	O
rationality	O
of	O
antibiotic	O
use	O
among	O
outpatients	O
in	O
Beijing	O
general	O
hospitals	I:C0020008
during	O
2015	O
.	O

Here	O
,	O
we	O
analyzed	O
the	O
prescriptions	B:C0033081
of	O
antibiotics	O
and	O
evaluated	O
the	O
rationality	O
of	O
antibiotic	O
use	O
among	O
outpatients	O
in	O
Beijing	O
general	O
hospitals	I:C0020008
during	O
2015	O
.	O

Here	O
,	O
we	O
analyzed	O
the	O
prescriptions	O
of	O
antibiotics	B:C0003232
and	O
evaluated	O
the	O
rationality	O
of	O
antibiotic	O
use	O
among	O
outpatients	O
in	O
Beijing	O
general	O
hospitals	I:C0020008
during	O
2015	O
.	O

Here	O
,	O
we	O
analyzed	O
the	O
prescriptions	O
of	O
antibiotics	O
and	O
evaluated	B:C0220825
the	O
rationality	O
of	O
antibiotic	O
use	O
among	O
outpatients	O
in	O
Beijing	O
general	O
hospitals	I:C0020008
during	O
2015	O
.	O

Here	O
,	O
we	O
analyzed	O
the	O
prescriptions	O
of	O
antibiotics	O
and	O
evaluated	O
the	O
rationality	O
of	O
antibiotic	B:C0003232
use	O
among	O
outpatients	O
in	O
Beijing	O
general	O
hospitals	I:C0020008
during	O
2015	O
.	O

Here	O
,	O
we	O
analyzed	O
the	O
prescriptions	O
of	O
antibiotics	O
and	O
evaluated	O
the	O
rationality	O
of	O
antibiotic	O
use	O
among	O
outpatients	O
in	O
Beijing	B:C4042832
general	O
hospitals	I:C0020008
during	O
2015	O
.	O

Here	O
,	O
we	O
analyzed	O
the	O
prescriptions	O
of	O
antibiotics	O
and	O
evaluated	O
the	O
rationality	O
of	O
antibiotic	O
use	O
among	O
outpatients	O
in	O
Beijing	O
general	B:C0020008
hospitals	I:C0020008
during	O
2015	O
.	O

We	O
collected	O
basic	O
medical	B:C0021689
insurance	I:C0021689
claim	O
data	O
from	O
January	O
1	O
,	O
2015	O
to	O
December	O
31	O
,	O
2015	O
in	O
507	O
general	O
hospitals	I:C0020008
of	O
Beijing	O
.	O

We	O
collected	O
basic	O
medical	O
insurance	I:C0021689
claim	O
data	O
from	O
January	O
1	O
,	O
2015	O
to	O
December	O
31	O
,	O
2015	O
in	O
507	O
general	B:C0020008
hospitals	I:C0020008
of	O
Beijing	O
.	O

We	O
collected	O
basic	O
medical	O
insurance	I:C0021689
claim	O
data	O
from	O
January	O
1	O
,	O
2015	O
to	O
December	O
31	O
,	O
2015	O
in	O
507	O
general	O
hospitals	I:C0020008
of	O
Beijing	B:C4042832
.	O

A	O
descriptive	B:C0678257
analysis	O
of	O
outpatient	O
antibiotic	O
prescribing	O
was	O
performed	O
.	O

A	O
descriptive	O
analysis	B:C0936012
of	O
outpatient	O
antibiotic	O
prescribing	O
was	O
performed	O
.	O

A	O
descriptive	O
analysis	O
of	O
outpatient	O
antibiotic	B:C0003232
prescribing	O
was	O
performed	O
.	O

The	O
Anatomical	B:C3540695
Therapeutic	I:C3540695
Chemical	I:C3540695
Classification	I:C3540695
/	I:C3540695
defined	I:C3540695
daily	I:C3540695
doses	I:C3540695
system	I:C3540695
was	O
used	O
to	O
evaluate	O
the	O
rationality	O
of	O
antibiotic	O
use	O
.	O

The	O
Anatomical	O
Therapeutic	I:C3540695
Chemical	I:C3540695
Classification	I:C3540695
/	I:C3540695
defined	I:C3540695
daily	I:C3540695
doses	I:C3540695
system	I:C3540695
was	O
used	O
to	O
evaluate	B:C0220825
the	O
rationality	O
of	O
antibiotic	O
use	O
.	O

The	O
Anatomical	O
Therapeutic	I:C3540695
Chemical	I:C3540695
Classification	I:C3540695
/	I:C3540695
defined	I:C3540695
daily	I:C3540695
doses	I:C3540695
system	I:C3540695
was	O
used	O
to	O
evaluate	O
the	O
rationality	O
of	O
antibiotic	B:C0003232
use	O
.	O

Over	O
the	O
study	B:C2603343
,	O
an	O
estimated	O
721,930	O
,	O
613,520	O
,	O
and	O
822,480	O
antibiotics	O
were	O
dispensed	O
in	O
primary	O
,	O
secondary	O
,	O
and	O
tertiary	O
general	O
hospitals	I:C0020008
corresponding	O
to	O
5.09	O
%	O
,	O
5.06	O
%	O
,	O
and	O
2.53	O
%	O
of	O
all	O
prescriptions	O
,	O
respectively	O
.	O

Over	O
the	O
study	O
,	O
an	O
estimated	O
721,930	O
,	O
613,520	O
,	O
and	O
822,480	O
antibiotics	B:C0003232
were	O
dispensed	O
in	O
primary	O
,	O
secondary	O
,	O
and	O
tertiary	O
general	O
hospitals	I:C0020008
corresponding	O
to	O
5.09	O
%	O
,	O
5.06	O
%	O
,	O
and	O
2.53	O
%	O
of	O
all	O
prescriptions	O
,	O
respectively	O
.	O

Over	O
the	O
study	O
,	O
an	O
estimated	O
721,930	O
,	O
613,520	O
,	O
and	O
822,480	O
antibiotics	O
were	O
dispensed	B:C1880359
in	O
primary	O
,	O
secondary	O
,	O
and	O
tertiary	O
general	O
hospitals	I:C0020008
corresponding	O
to	O
5.09	O
%	O
,	O
5.06	O
%	O
,	O
and	O
2.53	O
%	O
of	O
all	O
prescriptions	O
,	O
respectively	O
.	O

Over	O
the	O
study	O
,	O
an	O
estimated	O
721,930	O
,	O
613,520	O
,	O
and	O
822,480	O
antibiotics	O
were	O
dispensed	O
in	O
primary	O
,	O
secondary	O
,	O
and	O
tertiary	O
general	B:C0020008
hospitals	I:C0020008
corresponding	O
to	O
5.09	O
%	O
,	O
5.06	O
%	O
,	O
and	O
2.53	O
%	O
of	O
all	O
prescriptions	O
,	O
respectively	O
.	O

Over	O
the	O
study	O
,	O
an	O
estimated	O
721,930	O
,	O
613,520	O
,	O
and	O
822,480	O
antibiotics	O
were	O
dispensed	O
in	O
primary	O
,	O
secondary	O
,	O
and	O
tertiary	O
general	O
hospitals	I:C0020008
corresponding	O
to	O
5.09	O
%	O
,	O
5.06	O
%	O
,	O
and	O
2.53	O
%	O
of	O
all	O
prescriptions	B:C0033081
,	O
respectively	O
.	O

Antibiotic	O
combinations	O
represented	O
2.95	O
%	O
,	O
7.74	O
%	O
,	O
and	O
10.18	O
%	O
of	O
the	O
total	O
antibiotic	B:C0003232
prescriptions	O
,	O
respectively	O
.	O

Antibiotic	O
combinations	O
represented	O
2.95	O
%	O
,	O
7.74	O
%	O
,	O
and	O
10.18	O
%	O
of	O
the	O
total	O
antibiotic	O
prescriptions	B:C0033081
,	O
respectively	O
.	O

Expenditure	O
for	O
the	O
top	O
twenty	O
antibiotic	B:C0003232
s	O
in	O
primary	O
,	O
secondary	O
,	O
and	O
tertiary	O
general	O
hospitals	I:C0020008
was	O
RMB	O
42.92	O
,	O
65.89	O
,	O
and	O
83.26	O
million	O
Yuan	O
,	O
respectively	O
.	O

Expenditure	O
for	O
the	O
top	O
twenty	O
antibiotic	O
s	O
in	O
primary	O
,	O
secondary	O
,	O
and	O
tertiary	O
general	B:C0020008
hospitals	I:C0020008
was	O
RMB	O
42.92	O
,	O
65.89	O
,	O
and	O
83.26	O
million	O
Yuan	O
,	O
respectively	O
.	O

Cephalosporins	B:C3536856
were	O
the	O
most	O
frequently	O
prescribed	O
class	O
of	O
antibiotic	O
in	O
clinical	O
practice	I:C0008949
.	O

Cephalosporins	O
were	O
the	O
most	O
frequently	O
prescribed	O
class	O
of	O
antibiotic	B:C0003232
in	O
clinical	O
practice	I:C0008949
.	O

Cephalosporins	O
were	O
the	O
most	O
frequently	O
prescribed	O
class	O
of	O
antibiotic	O
in	O
clinical	B:C0008949
practice	I:C0008949
.	O

The	O
antibiotic	B:C0003232
s	O
used	O
inappropriately	O
included	O
azithromycin	O
enteric	O
-	I:C0039226
coated	I:C0039226
capsules	I:C0039226
,	O
compound	O
cefaclor	I:C0007537
tablets	O
and	O
nifuratel	O
nysfungin	I:C0028070
vaginal	O
soft	I:C1273013
capsules	I:C1273013
in	O
primary	O
hospitals	O
,	O
amoxicillin	O
and	O
clavulanate	O
potassium	I:C0137997
dispersible	O
tablets	I:C1273630
(	O
7:1	O
)	O
and	O
cefonicid	O
sodium	O
for	O
injection	O
in	O
secondary	O
hospitals	O
,	O
cefminox	O
sodium	I:C1529767
for	O
injection	O
and	O
amoxicillin	O
sodium	I:C0887551
and	O
sulbactam	O
sodium	I:C0282355
for	O
injection	O
in	O
tertiary	O
hospitals	O
.	O

The	O
antibiotic	O
s	O
used	O
inappropriately	O
included	O
azithromycin	B:C0052796
enteric	O
-	I:C0039226
coated	I:C0039226
capsules	I:C0039226
,	O
compound	O
cefaclor	I:C0007537
tablets	O
and	O
nifuratel	O
nysfungin	I:C0028070
vaginal	O
soft	I:C1273013
capsules	I:C1273013
in	O
primary	O
hospitals	O
,	O
amoxicillin	O
and	O
clavulanate	O
potassium	I:C0137997
dispersible	O
tablets	I:C1273630
(	O
7:1	O
)	O
and	O
cefonicid	O
sodium	O
for	O
injection	O
in	O
secondary	O
hospitals	O
,	O
cefminox	O
sodium	I:C1529767
for	O
injection	O
and	O
amoxicillin	O
sodium	I:C0887551
and	O
sulbactam	O
sodium	I:C0282355
for	O
injection	O
in	O
tertiary	O
hospitals	O
.	O

The	O
antibiotic	O
s	O
used	O
inappropriately	O
included	O
azithromycin	O
enteric	B:C0039226
-	I:C0039226
coated	I:C0039226
capsules	I:C0039226
,	O
compound	O
cefaclor	I:C0007537
tablets	O
and	O
nifuratel	O
nysfungin	I:C0028070
vaginal	O
soft	I:C1273013
capsules	I:C1273013
in	O
primary	O
hospitals	O
,	O
amoxicillin	O
and	O
clavulanate	O
potassium	I:C0137997
dispersible	O
tablets	I:C1273630
(	O
7:1	O
)	O
and	O
cefonicid	O
sodium	O
for	O
injection	O
in	O
secondary	O
hospitals	O
,	O
cefminox	O
sodium	I:C1529767
for	O
injection	O
and	O
amoxicillin	O
sodium	I:C0887551
and	O
sulbactam	O
sodium	I:C0282355
for	O
injection	O
in	O
tertiary	O
hospitals	O
.	O

The	O
antibiotic	O
s	O
used	O
inappropriately	O
included	O
azithromycin	O
enteric	O
-	I:C0039226
coated	I:C0039226
capsules	I:C0039226
,	O
compound	B:C0007537
cefaclor	I:C0007537
tablets	O
and	O
nifuratel	O
nysfungin	I:C0028070
vaginal	O
soft	I:C1273013
capsules	I:C1273013
in	O
primary	O
hospitals	O
,	O
amoxicillin	O
and	O
clavulanate	O
potassium	I:C0137997
dispersible	O
tablets	I:C1273630
(	O
7:1	O
)	O
and	O
cefonicid	O
sodium	O
for	O
injection	O
in	O
secondary	O
hospitals	O
,	O
cefminox	O
sodium	I:C1529767
for	O
injection	O
and	O
amoxicillin	O
sodium	I:C0887551
and	O
sulbactam	O
sodium	I:C0282355
for	O
injection	O
in	O
tertiary	O
hospitals	O
.	O

The	O
antibiotic	O
s	O
used	O
inappropriately	O
included	O
azithromycin	O
enteric	O
-	I:C0039226
coated	I:C0039226
capsules	I:C0039226
,	O
compound	O
cefaclor	I:C0007537
tablets	B:C0039225
and	O
nifuratel	O
nysfungin	I:C0028070
vaginal	O
soft	I:C1273013
capsules	I:C1273013
in	O
primary	O
hospitals	O
,	O
amoxicillin	O
and	O
clavulanate	O
potassium	I:C0137997
dispersible	O
tablets	I:C1273630
(	O
7:1	O
)	O
and	O
cefonicid	O
sodium	O
for	O
injection	O
in	O
secondary	O
hospitals	O
,	O
cefminox	O
sodium	I:C1529767
for	O
injection	O
and	O
amoxicillin	O
sodium	I:C0887551
and	O
sulbactam	O
sodium	I:C0282355
for	O
injection	O
in	O
tertiary	O
hospitals	O
.	O

The	O
antibiotic	O
s	O
used	O
inappropriately	O
included	O
azithromycin	O
enteric	O
-	I:C0039226
coated	I:C0039226
capsules	I:C0039226
,	O
compound	O
cefaclor	I:C0007537
tablets	O
and	O
nifuratel	B:C0028070
nysfungin	I:C0028070
vaginal	O
soft	I:C1273013
capsules	I:C1273013
in	O
primary	O
hospitals	O
,	O
amoxicillin	O
and	O
clavulanate	O
potassium	I:C0137997
dispersible	O
tablets	I:C1273630
(	O
7:1	O
)	O
and	O
cefonicid	O
sodium	O
for	O
injection	O
in	O
secondary	O
hospitals	O
,	O
cefminox	O
sodium	I:C1529767
for	O
injection	O
and	O
amoxicillin	O
sodium	I:C0887551
and	O
sulbactam	O
sodium	I:C0282355
for	O
injection	O
in	O
tertiary	O
hospitals	O
.	O

The	O
antibiotic	O
s	O
used	O
inappropriately	O
included	O
azithromycin	O
enteric	O
-	I:C0039226
coated	I:C0039226
capsules	I:C0039226
,	O
compound	O
cefaclor	I:C0007537
tablets	O
and	O
nifuratel	O
nysfungin	I:C0028070
vaginal	B:C1273013
soft	I:C1273013
capsules	I:C1273013
in	O
primary	O
hospitals	O
,	O
amoxicillin	O
and	O
clavulanate	O
potassium	I:C0137997
dispersible	O
tablets	I:C1273630
(	O
7:1	O
)	O
and	O
cefonicid	O
sodium	O
for	O
injection	O
in	O
secondary	O
hospitals	O
,	O
cefminox	O
sodium	I:C1529767
for	O
injection	O
and	O
amoxicillin	O
sodium	I:C0887551
and	O
sulbactam	O
sodium	I:C0282355
for	O
injection	O
in	O
tertiary	O
hospitals	O
.	O

The	O
antibiotic	O
s	O
used	O
inappropriately	O
included	O
azithromycin	O
enteric	O
-	I:C0039226
coated	I:C0039226
capsules	I:C0039226
,	O
compound	O
cefaclor	I:C0007537
tablets	O
and	O
nifuratel	O
nysfungin	I:C0028070
vaginal	O
soft	I:C1273013
capsules	I:C1273013
in	O
primary	O
hospitals	B:C0019994
,	O
amoxicillin	O
and	O
clavulanate	O
potassium	I:C0137997
dispersible	O
tablets	I:C1273630
(	O
7:1	O
)	O
and	O
cefonicid	O
sodium	O
for	O
injection	O
in	O
secondary	O
hospitals	O
,	O
cefminox	O
sodium	I:C1529767
for	O
injection	O
and	O
amoxicillin	O
sodium	I:C0887551
and	O
sulbactam	O
sodium	I:C0282355
for	O
injection	O
in	O
tertiary	O
hospitals	O
.	O

The	O
antibiotic	O
s	O
used	O
inappropriately	O
included	O
azithromycin	O
enteric	O
-	I:C0039226
coated	I:C0039226
capsules	I:C0039226
,	O
compound	O
cefaclor	I:C0007537
tablets	O
and	O
nifuratel	O
nysfungin	I:C0028070
vaginal	O
soft	I:C1273013
capsules	I:C1273013
in	O
primary	O
hospitals	O
,	O
amoxicillin	B:C0002645
and	O
clavulanate	O
potassium	I:C0137997
dispersible	O
tablets	I:C1273630
(	O
7:1	O
)	O
and	O
cefonicid	O
sodium	O
for	O
injection	O
in	O
secondary	O
hospitals	O
,	O
cefminox	O
sodium	I:C1529767
for	O
injection	O
and	O
amoxicillin	O
sodium	I:C0887551
and	O
sulbactam	O
sodium	I:C0282355
for	O
injection	O
in	O
tertiary	O
hospitals	O
.	O

The	O
antibiotic	O
s	O
used	O
inappropriately	O
included	O
azithromycin	O
enteric	O
-	I:C0039226
coated	I:C0039226
capsules	I:C0039226
,	O
compound	O
cefaclor	I:C0007537
tablets	O
and	O
nifuratel	O
nysfungin	I:C0028070
vaginal	O
soft	I:C1273013
capsules	I:C1273013
in	O
primary	O
hospitals	O
,	O
amoxicillin	O
and	O
clavulanate	B:C0137997
potassium	I:C0137997
dispersible	O
tablets	I:C1273630
(	O
7:1	O
)	O
and	O
cefonicid	O
sodium	O
for	O
injection	O
in	O
secondary	O
hospitals	O
,	O
cefminox	O
sodium	I:C1529767
for	O
injection	O
and	O
amoxicillin	O
sodium	I:C0887551
and	O
sulbactam	O
sodium	I:C0282355
for	O
injection	O
in	O
tertiary	O
hospitals	O
.	O

The	O
antibiotic	O
s	O
used	O
inappropriately	O
included	O
azithromycin	O
enteric	O
-	I:C0039226
coated	I:C0039226
capsules	I:C0039226
,	O
compound	O
cefaclor	I:C0007537
tablets	O
and	O
nifuratel	O
nysfungin	I:C0028070
vaginal	O
soft	I:C1273013
capsules	I:C1273013
in	O
primary	O
hospitals	O
,	O
amoxicillin	O
and	O
clavulanate	O
potassium	I:C0137997
dispersible	B:C1273630
tablets	I:C1273630
(	O
7:1	O
)	O
and	O
cefonicid	O
sodium	O
for	O
injection	O
in	O
secondary	O
hospitals	O
,	O
cefminox	O
sodium	I:C1529767
for	O
injection	O
and	O
amoxicillin	O
sodium	I:C0887551
and	O
sulbactam	O
sodium	I:C0282355
for	O
injection	O
in	O
tertiary	O
hospitals	O
.	O

The	O
antibiotic	O
s	O
used	O
inappropriately	O
included	O
azithromycin	O
enteric	O
-	I:C0039226
coated	I:C0039226
capsules	I:C0039226
,	O
compound	O
cefaclor	I:C0007537
tablets	O
and	O
nifuratel	O
nysfungin	I:C0028070
vaginal	O
soft	I:C1273013
capsules	I:C1273013
in	O
primary	O
hospitals	O
,	O
amoxicillin	O
and	O
clavulanate	O
potassium	I:C0137997
dispersible	O
tablets	I:C1273630
(	O
7:1	O
)	O
and	O
cefonicid	O
sodium	O
for	O
injection	B:C1272883
in	O
secondary	O
hospitals	O
,	O
cefminox	O
sodium	I:C1529767
for	O
injection	O
and	O
amoxicillin	O
sodium	I:C0887551
and	O
sulbactam	O
sodium	I:C0282355
for	O
injection	O
in	O
tertiary	O
hospitals	O
.	O

The	O
antibiotic	O
s	O
used	O
inappropriately	O
included	O
azithromycin	O
enteric	O
-	I:C0039226
coated	I:C0039226
capsules	I:C0039226
,	O
compound	O
cefaclor	I:C0007537
tablets	O
and	O
nifuratel	O
nysfungin	I:C0028070
vaginal	O
soft	I:C1273013
capsules	I:C1273013
in	O
primary	O
hospitals	O
,	O
amoxicillin	O
and	O
clavulanate	O
potassium	I:C0137997
dispersible	O
tablets	I:C1273630
(	O
7:1	O
)	O
and	O
cefonicid	O
sodium	O
for	O
injection	O
in	O
secondary	O
hospitals	B:C0019994
,	O
cefminox	O
sodium	I:C1529767
for	O
injection	O
and	O
amoxicillin	O
sodium	I:C0887551
and	O
sulbactam	O
sodium	I:C0282355
for	O
injection	O
in	O
tertiary	O
hospitals	O
.	O

The	O
antibiotic	O
s	O
used	O
inappropriately	O
included	O
azithromycin	O
enteric	O
-	I:C0039226
coated	I:C0039226
capsules	I:C0039226
,	O
compound	O
cefaclor	I:C0007537
tablets	O
and	O
nifuratel	O
nysfungin	I:C0028070
vaginal	O
soft	I:C1273013
capsules	I:C1273013
in	O
primary	O
hospitals	O
,	O
amoxicillin	O
and	O
clavulanate	O
potassium	I:C0137997
dispersible	O
tablets	I:C1273630
(	O
7:1	O
)	O
and	O
cefonicid	O
sodium	O
for	O
injection	O
in	O
secondary	O
hospitals	O
,	O
cefminox	B:C1529767
sodium	I:C1529767
for	O
injection	O
and	O
amoxicillin	O
sodium	I:C0887551
and	O
sulbactam	O
sodium	I:C0282355
for	O
injection	O
in	O
tertiary	O
hospitals	O
.	O

The	O
antibiotic	O
s	O
used	O
inappropriately	O
included	O
azithromycin	O
enteric	O
-	I:C0039226
coated	I:C0039226
capsules	I:C0039226
,	O
compound	O
cefaclor	I:C0007537
tablets	O
and	O
nifuratel	O
nysfungin	I:C0028070
vaginal	O
soft	I:C1273013
capsules	I:C1273013
in	O
primary	O
hospitals	O
,	O
amoxicillin	O
and	O
clavulanate	O
potassium	I:C0137997
dispersible	O
tablets	I:C1273630
(	O
7:1	O
)	O
and	O
cefonicid	O
sodium	O
for	O
injection	O
in	O
secondary	O
hospitals	O
,	O
cefminox	O
sodium	I:C1529767
for	O
injection	B:C1272883
and	O
amoxicillin	O
sodium	I:C0887551
and	O
sulbactam	O
sodium	I:C0282355
for	O
injection	O
in	O
tertiary	O
hospitals	O
.	O

The	O
antibiotic	O
s	O
used	O
inappropriately	O
included	O
azithromycin	O
enteric	O
-	I:C0039226
coated	I:C0039226
capsules	I:C0039226
,	O
compound	O
cefaclor	I:C0007537
tablets	O
and	O
nifuratel	O
nysfungin	I:C0028070
vaginal	O
soft	I:C1273013
capsules	I:C1273013
in	O
primary	O
hospitals	O
,	O
amoxicillin	O
and	O
clavulanate	O
potassium	I:C0137997
dispersible	O
tablets	I:C1273630
(	O
7:1	O
)	O
and	O
cefonicid	O
sodium	O
for	O
injection	O
in	O
secondary	O
hospitals	O
,	O
cefminox	O
sodium	I:C1529767
for	O
injection	O
and	O
amoxicillin	B:C0887551
sodium	I:C0887551
and	O
sulbactam	O
sodium	I:C0282355
for	O
injection	O
in	O
tertiary	O
hospitals	O
.	O

The	O
antibiotic	O
s	O
used	O
inappropriately	O
included	O
azithromycin	O
enteric	O
-	I:C0039226
coated	I:C0039226
capsules	I:C0039226
,	O
compound	O
cefaclor	I:C0007537
tablets	O
and	O
nifuratel	O
nysfungin	I:C0028070
vaginal	O
soft	I:C1273013
capsules	I:C1273013
in	O
primary	O
hospitals	O
,	O
amoxicillin	O
and	O
clavulanate	O
potassium	I:C0137997
dispersible	O
tablets	I:C1273630
(	O
7:1	O
)	O
and	O
cefonicid	O
sodium	O
for	O
injection	O
in	O
secondary	O
hospitals	O
,	O
cefminox	O
sodium	I:C1529767
for	O
injection	O
and	O
amoxicillin	O
sodium	I:C0887551
and	O
sulbactam	B:C0282355
sodium	I:C0282355
for	O
injection	O
in	O
tertiary	O
hospitals	O
.	O

The	O
antibiotic	O
s	O
used	O
inappropriately	O
included	O
azithromycin	O
enteric	O
-	I:C0039226
coated	I:C0039226
capsules	I:C0039226
,	O
compound	O
cefaclor	I:C0007537
tablets	O
and	O
nifuratel	O
nysfungin	I:C0028070
vaginal	O
soft	I:C1273013
capsules	I:C1273013
in	O
primary	O
hospitals	O
,	O
amoxicillin	O
and	O
clavulanate	O
potassium	I:C0137997
dispersible	O
tablets	I:C1273630
(	O
7:1	O
)	O
and	O
cefonicid	O
sodium	O
for	O
injection	O
in	O
secondary	O
hospitals	O
,	O
cefminox	O
sodium	I:C1529767
for	O
injection	O
and	O
amoxicillin	O
sodium	I:C0887551
and	O
sulbactam	O
sodium	I:C0282355
for	O
injection	B:C1272883
in	O
tertiary	O
hospitals	O
.	O

The	O
antibiotic	O
s	O
used	O
inappropriately	O
included	O
azithromycin	O
enteric	O
-	I:C0039226
coated	I:C0039226
capsules	I:C0039226
,	O
compound	O
cefaclor	I:C0007537
tablets	O
and	O
nifuratel	O
nysfungin	I:C0028070
vaginal	O
soft	I:C1273013
capsules	I:C1273013
in	O
primary	O
hospitals	O
,	O
amoxicillin	O
and	O
clavulanate	O
potassium	I:C0137997
dispersible	O
tablets	I:C1273630
(	O
7:1	O
)	O
and	O
cefonicid	O
sodium	O
for	O
injection	O
in	O
secondary	O
hospitals	O
,	O
cefminox	O
sodium	I:C1529767
for	O
injection	O
and	O
amoxicillin	O
sodium	I:C0887551
and	O
sulbactam	O
sodium	I:C0282355
for	O
injection	O
in	O
tertiary	O
hospitals	B:C0019994
.	O

Antibiotic	B:C0003232
use	O
in	O
Beijing	O
general	O
hospitals	I:C0020008
is	O
generally	O
low	O
;	O
however	O
,	O
inappropriate	O
antibiotic	O
use	O
still	O
exists	O
.	O

Antibiotic	O
use	O
in	O
Beijing	B:C4042832
general	O
hospitals	I:C0020008
is	O
generally	O
low	O
;	O
however	O
,	O
inappropriate	O
antibiotic	O
use	O
still	O
exists	O
.	O

Antibiotic	O
use	O
in	O
Beijing	O
general	B:C0020008
hospitals	I:C0020008
is	O
generally	O
low	O
;	O
however	O
,	O
inappropriate	O
antibiotic	O
use	O
still	O
exists	O
.	O

Antibiotic	O
use	O
in	O
Beijing	O
general	O
hospitals	I:C0020008
is	O
generally	O
low	O
;	O
however	O
,	O
inappropriate	O
antibiotic	B:C0003232
use	O
still	O
exists	O
.	O

Inappropriately	O
used	O
antibiotic	B:C0003232
s	O
should	O
be	O
subject	O
to	O
rigorous	O
control	O
and	O
management	O
,	O
and	O
public	O
policy	O
initiatives	O
are	O
required	O
to	O
promote	O
the	O
judicious	O
use	O
of	O
antibiotic	O
s	O
.	O

Inappropriately	O
used	O
antibiotic	O
s	O
should	O
be	O
subject	O
to	O
rigorous	O
control	O
and	O
management	O
,	O
and	O
public	O
policy	O
initiatives	O
are	O
required	O
to	O
promote	O
the	O
judicious	O
use	O
of	O
antibiotic	B:C0003232
s	O
.	O

